Intrapulmonary interleukin 1 mediates acute immune complex alveolitis in the rat by Warren, Jeffrey S.
Vol. 175, No. 2, 1991 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
March 15. 1991 Pages 604-610 
INTRAPULMONARY INTERLEUKIN 1 MEDIATES ACUTE IMMUNE 
COMPLEX ALVEOLITIS IN THE RAT 
Jeffrey S. Warren 
Department of Pathology, The University of Michigan Medical School 
1301 Catherine Street, Ann Arbor, Ml 48 109-0602 
Received January 31, 1991 
Interleukin la and p are polypeptide cytokines that possesses a wide variety of 
immunologic and intlammatory activities. We have examined the role of intrapulmonary 
interleukin 1 in the pathogenesis of acute IgG immune complex alveolitis in the rat. 
Intratracheal instillation of IgG anti-bovine serum albumin accompanied by intravenous infusion 
of bovine albumin results in acute neutrophil and complement-dependent alveolitis. Over the 
course of evolving lung injury there was a 1Zfold increase in bronchoalveolar lavage fluid 
interleukin 1 activity. Intratracheal instillation of neutralizing anti-interleukin lp antibodies 
upon induction of lung injury resulted in a dose-dependent reduction in lung injury as assessed 
by measurements of pulmonary hemorrhage and vascular permeability. Morphomenic analysis 
and measurements of myeloperoxidase activities in whole lung homogenates from rats that 
received anti-interleukin 10 revealed a pronounced reduction in neutrophil recruitment compared 
to positive controls. Incubation of isolated alveolar macrophages with preformed IgG immune 
complexes resulted in dose-dependent interleukin 1 secretion. These data suggest that 
intrapulmonary IL-1 activity plays a role in neutrophil recruitment and is necessary for the full 
development of acute IgG immune complex induced lung injury in the rat. 0 1991 Academic 
Press, Inc. 
Interleukin 1 has been implicated in a variety of immunologic and inflammatory 
processes (1, reviewed). Interleukin l-like activity has been recovered from a variety of 
inflamed tissues (2-6). Inoculation of highly purified or recombinant human IL-1 into the joints, 
skin, or eyes of experimental animals promotes localized acute inflammatory changes (7-9). h 
Y&Q studies indicate that IL-1 induces the upregulation of leukocyte adhesion molecules by 
several cell types, including endothelial cells (10-14). Exposure of endothelial cell monolayers 
to L-1 also results in the secretion of soluble inflammatory mediators including neutrophil 
chemotactic factor and monocyte chemoattractant protein- 1 (1516). 
Interleukin la and 0 are biochemically distinct, separately encoded molecules thought to 
be derived from a common ancestral gene (17,18). Interleukin lfl predominates in the 
circulation and other body fluids and is presently thought to be the more prevalent soluble form 
of this cytokine (1). A homologous region of IL-lo and IL 1 p, termed C-D, is the minimal 
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recognition site for IL- 1 receptors (1). Receptors for IL-l equally bind the a and p forms, both 
of which exhibit the same biological activities (1). 
In the present study we have analyzed the role of intrapulmonary IL- 1 in the pathogenesis 
of acute IgG immune complex alveolitis in the rat. The results of this study indicate that locally 
produced IL-l mediates acute immune complex-triggered alveolitis through a mechanism 
involving pulmonary neutrophil recruitment. 
MATERIALS AND METHODS 
Animal Model of Immune Comule Alveom. Male Long-Evans specific pathogen free 
rats (350 g; Charles River Breeding Lab&tories, Inc., Wilmington, MA) were used for all 
studies. Intraperitoneal injections of ketamine (2.5-5.0 mg/lOO g body wt) and sodium 
pentobarbital (5 mg/lOO g body wt) were given for sedation and anesthesia. Immune complex 
lung injury was induced as previously described (19). Antibody solutions (250 Irg anti-BSA 
unless otherwise specified) were instilled into the lungs via a tracheal cannula. Antigen (BSA, 
10 mg) was injected intravenously. Rats were sacrificed at the indicated times and BAL fluid 
harvested (see below) or lung injury quantitated. Pulmonary injury was quantitated by 
permeability measurements as well as by morphometric analysis (19,20). 
Collection of BAL Fluid and Isolat’on of Alveolar Macronhw Alveolar macrophages 
and bronchoalveolar lavage fluid were re&ered as previously described (20). At least 90% of 
the administered fluid (5 ml) was always recovered, centrifuged (400 g; 7 min) to remove cells, 
and stored at -2OOC until analysis. 
Mornhometric Analvsis of Lune Iniuty Transmission electron micrographs were 
prepared from whole lungs fixed in 4% glutaraldehyde under constant pressure inflation (25 cm 
H20), washed in 0.1 M cacodylate buffer (pH 7.3), and embedded in plastic. l-pm-thick 
sections were stained with toluidine blue and processed for transmission electron microscopy by 
using a 401 transmission electron microscope (401; Philips Electronic Instruments, Mahwah, 
NJ). As previously described, morphometric analysis was carried out by experienced electron 
microscopist (R.G. Kunkel) who was blinded to sample origin (20). For each condition five lung 
samples were examined. In each sample, 45-60 randomly selected 40x microscopic fields were 
analyzed. 
Preparation of IgG anti-BSA. Rabbit IgG rich in antibody directed against BSA was used 
to induce lung injury and to form precipitating IgG-BSA immune complexes. Antibody content 
and production of immune complexes have been previously described in detail (19). The IgG 
anti-BSA and BSA (low endotoxin; ICN Biomedicals, Costa Mesa, CA) preparations contained 
co.02 @ml and 0.012 @ml of endotoxin activity, respectively, as estimated using the Limulus 
amebocyte lysate assay (E-toxate; Sigma Chemical Co., St. Louis, MO). Antigen-antibody 
equivalence for these reagents has previously been shown to occur at 1:5 (wt/wt) ratio (19). 
Prenaration of TNF and IL-l-rich Conditioned Medium from Alveolar Macrouhaees 
Rat alveolar macrophages were suspended in RPMI 1640 (KC Biological, Lenexa, KS); 
supplemented with 100 U/ml penicillin, 100 @ml streptomycin, 300 pg/ml fresh glutamine, and 
10% heat-inactivated $$tal calf serum (FCS; Gibco Laboratories, Grand Island, NY). Alveolar 
macrophages (2 x 10 /ml) were plated in 35mm polystyrene dishes (Corning Glass Works, 
Coming, NY) and maintained in a humidified 5% CO2 atmosphere at 37OC to allow 
macrophages to adhere. After 2 h, the dishes were. gently washed twice with serum-free 37OC 
RPM1 1640 and Escherichia & lipopolysaccharide 011 l:B4 (Sigma Chemical Co.) (10 pg/ml) 
was added to culture dishes. The dishes were maintained for 4 h in serum-free RPMI under the 
same conditions as above. After the incubation period, supematants were collected, and aliquots 
assayed for IL- 1 and TNF activity. 
IL- 1 assay. IL- 1 levels were measured by means of thymocyte cogroliferation assay, as 
modified from the procedure of Mizel et. al. (21). Briefly, 5 x 10 murine (C3H/HeJ) 
thymocytes in 0.1 ml of complete RPMI 1640 containing 2.5 ~tg/ml of phytohemagglutinin 
(Burroughs Welcome, Research Triangle Park, NC) were added to each well of a 96-well 
605 
Vol. 175, No. 2, 1991 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
microtiter plate. Equal volumes of log2 dilutions of sample were added to the wells in triplicate. 
+fter 66 h incubation at 37O C in 5% co219596 air, the thymocytes were pulsed with 0.5 pCi 
[ Hhhymidine (6.9 Ci/nmol; ICN Nutritional Biochemicals, e, CA) and collected 6 h later 
on glass fiber strips using an automatic cell harvester. Thymidine incorporation was 
determined by using a liquid scintillation counter. For standardization, data are expressed as 
units/ml based on a recombinant human IL-lp standard (The Upjohn Co. Kalamazoo, MI) 
assayed concomitantly with unknown samples. 
TNF activity was measured by means of modification of the procedure of TNF Assay. 
Ruff and Gifford (22). Briefly, equal volumes of log dilutions (final volume 0.1 ml) of sarnple- 
containing media were made in 96well microtiter p ates 1 (Costar, Cambridge, MA) containing 
target LM cells (mouse fibro 
Culture Collection) (5 x B 
last cell line derived from NClC clone 929; American Type 
10 cells per 0.1 ml) in the presence of actinomycin D (final 
concentration, 1 pg/ml). In a separate set of wells, a standard consisting of serially diluted 
recombinant human TNF (Cetus Immune Laboratories, Palo Alto, CA) was added. The cells 
were incubated at 37OC for 18 h, the supematants discarded, and the remaining viable adherent 
cells washed with PBS and then stained by adding crystal violet (0.2% in 2% ethanol) for 5 min. 
Microtiter plates were rinsed three times with PBS and allowed to air dry. The absorbance of 
each well was read at 620 nm with a MicroELISA Autoreader (BioTek Instruments, Winooski, 
VT). Units of TNF are defined as the reciprocal of the dilution at which 50% cytolysis occurs. 
Preparation of Iffi anti-IL-10 Antibodiq. Anti-IL- lp was produced by immunization of 
rabbits with recombinant murine IL-lp (Genzyme, Boston, MA). The resulting antiserum was 
affinity purified using a protein A Sepharose column (Sigma). Anti-IL-l serum was diluted 1:l 
with PBS (100 mM phosphate, pH 8.0, 150 n&i NaCl) and applied slowly to the PBS-washed 
column. After extensive washing with PBS, the column was stripped with 100 mM sodium 
acetate buffer, pH 3.0 Fractions (1 ml) were collected in tubes containing 50 ~1 of 1M Tris 
buffer, pH 8.0. The affinity purified IgG fraction was then dialyzed against PBS and tested for 
specificity against IL- 1. 
. . . 
Whole Lung Mveloperoxida,se Actrvm Pulmonary neutrophil recruitment was 
quantitated by measuring whole lung myeloperoxidase as previously described (23). Whole 
lungs were homogenized with a Polytron homogenizer (4 x 10s at a setting of 4) using 6 ml of 
homogenization buffer. The homogenization buffer (50 n&l phosphate, pH 6.0) contained 0.5% 
hexadecyltrimethyl ammonium bromide (Sigma) and 5mM EDTA. Homogenized samples were 
then sonicated (3 x 10s at a setting of 5) and centrifuged (3,000 x g; 30 mitt) at 4Oe. 
Myeloperoxidase activity in supematants was assayed by measuring the change in A460 
resulting from decomposition of H202 in the presence of o-dianisidine (24). 
RESULTS 
mbomdon of hmapulmonarv U-1 Dumune Corrglex Induced a. 
Bronchoalveolar lavage fluids were examined for the presence of IL- 1 as a function of time after 
airway instillation of anti-BSA and intravenous infusion of BSA. A modest increase in B-1 
activity could be detected in the first two hours (Figure 1). After 2 hrs. there was a rapid rise in 
BAL IL-1 activity; by 4 hrs. IL-1 levels had increased 12-fold. In rats that received anti-BSA in 
the absence of antigen or heat denatured anti-BSA in the presence of antigen, the BAL fluid at 4 
hrs. contained less than 5 units/ml of IL-l. These data suggest that endotoxin contamination of 
the anti-BSA or BSA is not responsible for eliciting BAL fluid IL1 and that the inuapulmonary 
elaboration of IL-1 is dependent on pulmonary immune complex formation. 
In Vitro Pra IL1 bv Rat Alv-. Incubation of isolated alveolar 
macrophages with increasing concentrations of 1gG:BSA immune complexes resulted in dose- 
dependent release of IL- 1 activity (Figure 2). Incubation of macrophages with IgG alone or BSA 
alone resulted in minimal IL-1 release, suggesting that IL-1 secretion is dependent on the 
presence of intact immune complexes. 
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Fimn-e 1. Elaboration of intrapulmonary (BAL fluid) IL-1 during the evolution of IgG 
immune complex lung injury. The data expressed represent the means +. SEM of three 
experiments in which three to five rats were employed for each variable. Data were analyzed by 
one-way analysis with significance assigned for p < .05 (28). 
versus injured rats of time zero and negative control rats. 
* Indicates significant differences 
Figure 2. Preformed 1gG:BSA immune complexes trigger IL-l release by isolated 
alveolar macrophages. Alveolar macrophages suspended in RPM1 1640 with 10% heat- 
inactivated FBS were allowed to adhere to polystyrene culture dishes (2 x 10 /35 mm dish), 
washed, and incubated for 4 hrs. in serum-free RPM1 1640 (2 ml) containing the indicated 
quantity of immune complex, IgG alone or BSA alone. The data represent the means + SEM of 
two experiments in which triplicate determination were made. All values are normalized for 
adherent cell number. 
. . . 
Jn Vitro Neutralization of Rat I?,-1 Acnvltv wth Soec ific Anti-& 1 fi AntibodieS. 
Aliquots of serum-free IL-I and TNF-rich conditioned media from rat alveolar macrophage 
cultures were used to test the neutralizing capacity of the anti-IL-lp antibody and to verify the 
absence of cross reactivity with another relevant cytokine, TNF. Affinity purified IgG anti-IL- 
lp antibodies blocked IL-l activity in a dose dependent manner (Figure 3). Equivalent 
concentrations of irrelevant affinity purified rabbit IgG had no neutralizing effect on IL-l 
activity. Even at concentrations of 100 @ml, neither anti-IL-lp nor irrelevant rabbit IgG had 
significant blocking effects on TNF activity (114 units/ml) present in the conditioned medium 
(data not shown). 
Blockade of I@ Immune Comulex Alveolitis with Anti-IL- 1 B Antibodies Intratracheal 
instillation of anti-IL-l/3 resulted in a 58% reduction in IgG immune complex induced lung 
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Figure 3. In vitro neutralization of IL-1 activity with anti-IL-lp. Rat IL-1 (and TNF) 
activity was assayed from serum-free conditioned medium obtained from lipopolysaccharide- 
stimulated rat alveolar macrophages. The data represent the means + SEM of two experiments 
in which each variable was assayed in triplicate. A common stock of conditioned medium was 
used for each experiment. 
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Table 1. Blockade of IgG Immune Complex Lung Injury and 
Neutmphil Influx with Anti-IL-l p Antibodies 
Intervention Lune Iniurv 
P.I.* 
Neuhvphil Influx 
Hemorrhage PMN/4OXHPF h@O+ 
(RBC/40X HPF) 
No intmnvenous BSA 
(Negative control) 
0.14 f. .l 221 321 .02 + .02 
Nonspecific IgG; 1OOpg 
(Positive Control) 
Anti-IL-Q; 1OOpg 
49k7 7 $86,7-j .;&.0’7 
20+5 T 37&5~05.19iO~ 
*Permeability index (see Materials and Methods). 
+ Myelopemxidase activity (whole lung homogenates) is expressed as A O.D. (b) per minute 
resulting from decomposition of Hz@ in presence of odianisidine (24). 
SData were analyzed by one-way analysis of variance (28). 
1). Substitution of equivalent concentrations of heat inactivated anti-IL-lfl (data not shown) or 
nonspecific rabbit IgG (Table 1) failed to suppress immune complex lung injury. In order to 
confirm that intratracheal instillation of anti-IL-lp reduced intraapulmonary IL-1 activity, we 
measured BAL fluid IL-1 activity 4 hrs. after lung injury was induced. Bronchoalveolar lavage 
fluid from possitive control rats contained 26 + 3 units/ml of IL-1 activity while rats that 
received anti-IL- 1 p contained 7 + 3 units/ml of IL- 1 activity. 
Evidence that IL-113 Contributes to Lung Inbrv ThroncJh a Neutroohil Medid 
Mechanism. Morphometric analysis of lung sections confirmed that there was diminished 
neutrophil influx into the lungs of rats treated with anti-ILlJ3 compared to positive controls 
(Table 1). Myeloperoxidase measurements from whole rat lungs obtained from each of the 
treatment groups confirmed that there was a marked reduction of myeloperoxidase activity in the 
lungs of rats treated with anti-IL-lp antibodies compared to positive control rats (Table 1). 
These data suggest that IL-lp is necessary for the maximum recruitment of neutrophils into the 
lungs of animals with developing immune complex alveolitis. 
DISCUSSION 
A variety of proinflammatory activities have been attributed to IL-1 (1). Data derived 
from this study suggest that intrapulmonary IL-1 mediates acute immune complex alveolitis 
through a mechanism involving neutrophil recruitment. We have previously demonstrated an 
analogous role for TNF in the patbogenesis of acute alveolitis (20). Several points should be 
addressed. Anti-IL-1B does not completely neutralize IL-1 activity, either in isolated alveolar 
macrophage supematants, or retrieved BAL fluid from rats with evolving lung injury. This may 
be attributable to incomplete neutralizing capacity of anti-IL-@ and/or the presence of non-cross 
reacting IL-la. While several studies suggest that IL-l/3 predominates over IL-lo in bodily 
fluids, the relative proportions of IL- lcx and IL- 1 p in rat BAL are unknown. In addition, the role 
of cell-associated IL-1 (presumed to the predominantly IL-la) in acute alveolitis is unclear. 
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Several IL-l-dependent pathways of neutrophil recruitment could be operative in this 
model. b yiga studies indicate that IL-l can trigger platelet-activating factor and neutrophil 
chemotactic factor production by cells indigenous to the lung (1525). Interleukin-1 can also 
trigger the expression of endothelium-leukocyte adhesion molecule-l by endothelial cells (13). 
All of these mediators could conceivably participate in the pathogenesis of acute immune 
complex alveolitis. The role of IL-l may be direct and/or indirect. For instance, local IL-l 
production may regulate TNF secretion (or y& ye& (26,27). Additional studies wi!l be 
required to elucidate the complex relationships that exist among such inflammatory mediator 
systems. 
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